Back to search
FDAFDA · Food and drugs·Recall number D-1126-2017

Morphine Sulfate Oral Solution, 100 mg/ 5 mL (20 mg/mL), packaged in a 1 oz. bottle containing 30 mL with an oral syringe, Rx Only, Manufactured by: Tris Pharma, Inc. Monmouth Junction, NJ 08852, NDC 27808-082-01

Published September 6, 2017 · Recall initiated: June 15, 2017

Summary

FDA records drug Class II recall D-1126-2017, published September 6, 2017 and initiated June 15, 2017. Recalling firm: Tris Pharma Inc.; Status: Terminated; Reported quantity: 34,824 bottles; Lot: Lot #: 08215001A, Exp 6/30/2017; 08215002A, 08215004A, Exp 7/31/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container: Oral solution leaking from container.

What to do

Voluntary: Firm initiated · Letter

Get an email if MORPHINE SULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MORPHINE SULFATE
Manufacturer
Tris Pharma Inc.
Distributor
U.S.A. Nationwide
UPC
0327808082015
Lot
Lot #: 08215001A, Exp 6/30/2017; 08215002A, 08215004A, Exp 7/31/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Morphine Sulfate Oral Solution, 100 mg/ 5 mL (20 mg/mL), packaged in a 1 oz. bottle containing 30 mL with an oral syringe, Rx Only, Manufactured by: Tris Pharma, Inc. Monmouth Junction, NJ 08852, NDC 27808-082-01 recalled?

Yes. FDA published recall D-1126-2017 on September 6, 2017. Reported hazard: Defective container: Oral solution leaking from container.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MORPHINE SULFATE. UPC: 0327808082015.